Elevated LIGHT level in patients with type 2 diabetes (Halvorsen et al., 2016)LIGHT-mediated inflammation implicated in nonalcoholic fatty liver disease (Herrero-Cervera et al., 2019). Here, TNFSF14 is linked to metabolic dysfunction-associated steatotic liver disease.